EASL's flagship publication, the Journal of Hepatology has been awarded an Impact Factor of 10.401. According to Thomson Reuters, these results make the Journal of Hepatology the fastest growing and most consistently impactful hepatology publication over the past 8 years.
This now places the Journal of Hepatology 2nd in the field of “Hepatology" (source: Thomson® Scientific) and 5th in the field of 'Gastroenterology and Hepatology'. “We are delighted with these results that recognise the high-quality contribution that the Journal of Hepatology makes every month to the liver and scientific communities at large," Editor-in-Chief, Professor Didier Samuel, explains “They are testament to the support that EASL - the 'Home of Hepatology' - provides."
This is the highest Impact factor that the Journal has ever achieved and marks EASL's commitment to providing the liver community with the most up-to-date work and data of the highest quality. “We have succeeded in positioning the journal as a leader in the field of hepatology, and I wish to thank the outstanding work done by all the authors, Editorial team, and Editorial office in Geneva," said EASL Secretary General, Markus Peck.
Thomson Reuter's announcement marks the sustained efforts of the editorial office, pioneered by Editor-in-Chief Professor Didier Samuel and EASL's Editorial Office, who have overseen major improvements to the quality of the journal. Their efforts for outstanding relevance in the field have accordingly been recognised by Thomson Reuters.
Further information on the Journal of Hepatology.
Become a Member of EASL and receive the Journal every month, as well as many other benefits.
High consumption of red and processed meat linked to non-alcoholic fatty liver disease and insulin resistance
Gastrointestinal hormone measurably improved symptoms of non-alcoholic fatty liver disease
Raising awareness about alcohol-related liver disease in women
Subscribe to the EASL newsletter